Adverum Biotechnologies/ US00773U2078 /
2024-07-26 9:59:57 PM | Chg. +0.03 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
8.15USD | +0.37% | 9,882 Turnover: 79,315.16 |
-Bid Size: - | -Ask Size: - | 8.52 | 7.84 |
GlobeNewswire
06-18
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
GlobeNewswire
06-11
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
05-23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
05-09
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire
05-01
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire
04-25
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientif...
GlobeNewswire
03-18
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pip...
GlobeNewswire
02-28
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
GlobeNewswire
02-12
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Confe...
GlobeNewswire
02-08
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Tr...
GlobeNewswire
02-01
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Res...
GlobeNewswire
01-29
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
GlobeNewswire
2023-12-07
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meet...
GlobeNewswire
2023-11-28
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
GlobeNewswire
2023-11-09
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
GlobeNewswire
2023-11-06
Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors
GlobeNewswire
2023-11-04
Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study ...